These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 10548188

  • 1. Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group.
    Reeves JH, Butt WW, Shann F, Layton JE, Stewart A, Waring PM, Presneill JJ.
    Crit Care Med; 1999 Oct; 27(10):2096-104. PubMed ID: 10548188
    [Abstract] [Full Text] [Related]

  • 2. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.
    Reeves JH, Cumming AR, Gallagher L, O'Brien JL, Santamaria JD.
    Crit Care Med; 1999 Oct; 27(10):2224-8. PubMed ID: 10548211
    [Abstract] [Full Text] [Related]

  • 3. Blood filtration in children with severe sepsis: safe adjunctive therapy.
    Reeves JH, Butt WW.
    Intensive Care Med; 1995 Jun; 21(6):500-4. PubMed ID: 7560493
    [Abstract] [Full Text] [Related]

  • 4. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
    Presneill JJ, Waring PM, Layton JE, Maher DW, Cebon J, Harley NS, Wilson JW, Cade JF.
    Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury.
    Parsons PE, Eisner MD, Thompson BT, Matthay MA, Ancukiewicz M, Bernard GR, Wheeler AP, NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network.
    Crit Care Med; 2005 Jan; 33(1):1-6; discussion 230-2. PubMed ID: 15644641
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A phase II randomized, controlled trial of continuous hemofiltration in sepsis.
    Cole L, Bellomo R, Hart G, Journois D, Davenport P, Tipping P, Ronco C.
    Crit Care Med; 2002 Jan; 30(1):100-6. PubMed ID: 11902250
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.
    Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R.
    JAMA; 2002 Jan; 273(12):934-41. PubMed ID: 7884952
    [Abstract] [Full Text] [Related]

  • 10. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.
    Abraham E, Glauser MP, Butler T, Garbino J, Gelmont D, Laterre PF, Kudsk K, Bruining HA, Otto C, Tobin E, Zwingelstein C, Lesslauer W, Leighton A.
    JAMA; 1997 May 21; 277(19):1531-8. PubMed ID: 9153367
    [Abstract] [Full Text] [Related]

  • 11. Epidemiology of sepsis and multiple organ dysfunction syndrome in children.
    Proulx F, Fayon M, Farrell CA, Lacroix J, Gauthier M.
    Chest; 1996 Apr 21; 109(4):1033-7. PubMed ID: 8635327
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis.
    Yekebas EF, Eisenberger CF, Ohnesorge H, Saalmüller A, Elsner HA, Engelhardt M, Gillesen A, Meins J, The M, Strate T, Busch C, Knoefel WT, Bloechle C, Izbicki JR.
    Crit Care Med; 2001 Jul 21; 29(7):1423-30. PubMed ID: 11445702
    [Abstract] [Full Text] [Related]

  • 15. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children.
    Rey C, Los Arcos M, Concha A, Medina A, Prieto S, Martinez P, Prieto B.
    Intensive Care Med; 2007 Mar 21; 33(3):477-84. PubMed ID: 17260130
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis. The rhIL-1ra Phase III Sepsis Syndrome Study Group.
    Knaus WA, Harrell FE, LaBrecque JF, Wagner DP, Pribble JP, Draper EA, Fisher CJ, Soll L.
    Crit Care Med; 1996 Jan 21; 24(1):46-56. PubMed ID: 8565538
    [Abstract] [Full Text] [Related]

  • 18. Sepsis severity is the major determinant of circulating thrombopoietin levels in septic patients.
    Zakynthinos SG, Papanikolaou S, Theodoridis T, Zakynthinos EG, Christopoulou-Kokkinou V, Katsaris G, Mavrommatis AC.
    Crit Care Med; 2004 Apr 21; 32(4):1004-10. PubMed ID: 15071393
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.